Eclipse 2L— 510(k) K183045

Name: FDA 510(k) clearance K183045
Creator: U.S. Food and Drug Administration
Published: 2019-04-30

Substantially Equivalent

Balt USA, LLC

FDA 510(k) clearance K183045 for Eclipse 2L, Substantially Equivalent on 2019-04-30. Applicant: Balt USA, LLC. Device class: 2.

Clearance details

Applicant: Balt USA, LLC
Product code: Code MJN
Device class: Class 2
Regulation: 21 CFR 870.4450
Advisory panel: Cardiovascular
Date received: 2018-11-02
Decision date: 2019-04-30
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Irvine, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code MJN

view all

K243795 — pREBOA-PRO Catheter2025-09-05
K251358 — Bridge Plus Occlusion Balloon (590-002)2025-06-24
K221294 — preCARDIA Occlusion System2023-06-30
K214060 — LANDMARK REBOA Catheter2022-09-19
K211610 — Fogarty Occlusion Catheter2022-02-14

More clearances from Balt USA, LLC

view all

K260199 — SLIM Microcatheter2026-07-13
K254223 — Next Generation 088 Catheter2026-04-16
K254221 — Optima Coil System (OptiOne Coil System)2026-01-27
K252569 — Carrier XL Delivery Catheter2025-10-22
K252700 — Optima Coil System (Optima Packing Coil System)2025-09-26

Adverse events under product code MJN

product code MJN

Death: 31
Injury: 240
Malfunction: 827
Total: 1,098

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.